Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras association domain family member 3 is a ubiquitously expressed protein containing a Ras association (RA) domain that acts as a Ras effector and a tumor suppressor. RASSF3 directly interacts with the E3 ubiquitin ligase MDM2, facilitating its ubiquitination and stabilization of p53, thus promoting p53-dependent transcription of genes that regulate cell cycle arrest and apoptosis. Loss or silencing of RASSF3 impairs DNA damage-induced apoptosis, disrupts cell-cycle checkpoints, and diminishes p53-mediated genomic integrity. Its function is impaired in certain tumors, notably pituitary adenoma and cancers associated with specific single nucleotide polymorphisms. It is not a receptor, enzyme, transporter, or transcription factor, but rather a signal transduction and tumor suppressor protein with a highly conserved domain structure.
For hypothetical therapies, would likely involve modulation of RASSF3 function to stabilize p53, induce cell cycle arrest, and promote apoptosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras association domain family member 3 (RASSF3).